4.5 Article

Role of host β1-and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors

Journal

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Volume 388, Issue 12, Pages 1317-1331

Publisher

SPRINGER
DOI: 10.1007/s00210-015-1165-7

Keywords

beta-adrenergic receptors; Catecholamines; Melanoma; Antibody validation

Funding

  1. Ministero della Salute [RF-2011-02351158]
  2. Regione Toscana
  3. Ente Cassa di Risparmio di Firenze

Ask authors/readers for more resources

Complex interactions between tumor cells and their surrounding compartment are strongly influenced by the host in which the tumor grows. In melanoma, for instance, stress-associated norephinephrine (NE), acting at beta-adrenergic receptors (beta-ARs), stimulates melanoma cell proliferation and tumor angiogenesis. Among beta-ARs, beta 3-ARs play a role acting not only at tumor cells but also at non-neoplastic stromal cells within the melanoma. In the present study, we used a murine model of B16 melanoma to evaluate the role of the host beta 1- and beta 2-ARs in melanoma growth and we determined whether the role of beta 3-ARs can be influenced by the absence of stromal beta 1- and beta 2-ARs. As compared to wild-type mice, beta 1/2-AR knockout mice displayed (i) increased intratumoral levels of both NE and beta 3-ARs, as evidentiated at both messenger and protein levels; (ii) increased tumor vascularization; (iii) decreased tumor cell proliferation but increased tumor cell apoptosis; and (iv) increased responsiveness to intratumoral injection of the beta 3-AR blocker L-748,337 in terms of decrease in tumor growth, tumor vascular response, tumor cell proliferation, and increase in tumor cell death. These findings together validate the role of beta-AR signaling in melanoma microenvironment suggesting that non-neoplastic stromal cells may be targeted by beta-AR-related drugs. The additional fact that beta 3-ARs play an important role in melanoma growth suggests selective beta 3-AR antagonists as important proapoptotic agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Pediatrics

Haematohidrosis treated with propranolol: a case report

Franco Ricci, Teresa Oranges, Elio Novembre, Maria Luisa Della Bona, Giancarlo la Marca, Maurizio de Martino, Luca Filippi

ARCHIVES OF DISEASE IN CHILDHOOD (2019)

Article Pharmacology & Pharmacy

β3-Adrenoceptor as a potential immuno-suppressor agent in melanoma

Maura Calvani, Gennaro Bruno, Massimo Dal Monte, Romina Nassini, Filippo Fontani, Arianna Casini, Lorenzo Cavallini, Matteo Becatti, Francesca Bianchini, Francesco De Logu, Giulia Forni, Giancarlo la Marca, Lido Calorini, Paola Bagnoli, Paola Chiarugi, Alberto Pupi, Chiara Azzari, Pierangelo Geppetti, Claudio Favre, Luca Filippi

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival

Amada Pasha, Marina Vignoli, Angela Subbiani, Alessio Nocentini, Silvia Selleri, Paola Gratteri, Annalisa Dabraio, Tommaso Casini, Luca Filippi, Ilaria Fotzi, Claudio Favre, Maura Calvani

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Pediatrics

Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study

Luca Filippi, Giacomo Cavallaro, Elettra Berti, Letizia Padrini, Gabriella Araimo, Giulia Regiroli, Genny Raffaeli, Valentina Bozzetti, Paolo Tagliabue, Barbara Tomasini, Annalisa Mori, Giuseppe Buonocore, Massimo Agosti, Angela Bossi, Gaetano Chirico, Salvatore Averse, Pina Fortunato, Silvia Osnaghi, Barbara Cavallotti, Martina Suzani, Maurizio Vanni, Giulia Borsari, Simone Donati, Giuseppe Nascimbeni, Daniel Nardo, Stefano Piermarocchi, Giancarlo la Marca, Giulia Forni, Silvano Milani, Ivan Cortinovis, Maura Calvani, Paola Bagnoli, Massimo Dal Monte, Anna Maria Calvani, Alessandra Pugi, Eduardo Villamor, Gianpaolo Donzelli, Fabio Mosca

FRONTIERS IN PEDIATRICS (2019)

Editorial Material Pediatrics

Decompressive Fasciotomy in an Extremely Preterm Newborn with Compartment Syndrome

Gilda Belli, Giuseppe Cucca, Luca Filippi

JOURNAL OF PEDIATRICS (2019)

Review Oncology

Current Therapies and New Targets to Fight Melanoma: A Promising Role for the beta 3-Adrenoreceptor

Luca Filippi, Gennaro Bruno, Vladana Domazetovic, Claudio Favre, Maura Calvani

CANCERS (2020)

Review Pharmacology & Pharmacy

A safety review of drugs used for the treatment of retinopathy of prematurity

Luca Filippi, Massimo Dal Monte

EXPERT OPINION ON DRUG SAFETY (2020)

Article Cell Biology

Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus

Alessandro Pini, Camilla Fazi, Patrizia Nardini, Maura Calvani, Sergio Fabbri, Alessandro Guerrini, Giulia Forni, Giancarlo La Marca, Arianna Carolina Rosa, Luca Filippi

CELLS (2020)

Article Pediatrics

Infantile hemangiomas β3-adrenoceptor overexpression is associated with nonresponse to propranolol

Andrea Bassi, Cesare Filippeschi, Teresa Oranges, Chiara Caporalini, Alessandro Pini, Patrizia Nardini, Roberta Marie Gentile, Luca Filippi

Summary: The research found a significant increase in the expression of beta(3)-AR in hemangioma biopsies from patients nonresponsive to propranolol treatment. This suggests a possible role of beta(3)-AR in the pathogenesis of hemangiomas and a potential new therapeutic target.

PEDIATRIC RESEARCH (2022)

Review Chemistry, Medicinal

beta 3-Adrenoceptor, a novel player in the round-trip from neonatal diseases to cancer: Suggestive clues from embryo

Luca Filippi, Alessandro Pini, Maurizio Cammalleri, Paola Bagnoli, Massimo Dal Monte

Summary: The role of beta-adrenoceptors in hypoxia-driven diseases, such as infantile hemangiomas and retinopathy of prematurity, has been highlighted. The upregulation of beta 3-ARs by hypoxia in both cancer and embryo development suggests potential similarities in their functions.

MEDICINAL RESEARCH REVIEWS (2022)

Review Oncology

The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma

Agata Janowska, Michela Iannone, Cristian Fidanzi, Marco Romanelli, Luca Filippi, Marzia Del Re, Manuella Martins, Valentina Dini

Summary: This paper reviews the genetic profile of melanoma cells from their appearance, through the dormant state to their reactivation leading to metastasis. A complete genetic profile will identify the genes responsible for metastasis appearance, contributing to the creation of new therapeutic targets that keep cells in a dormant state and prevent melanoma tumor cells from spreading.

CANCERS (2022)

Article Cell Biology

HIF-1-Dependent Induction of β3 Adrenoceptor: Evidence from the Mouse Retina

Rosario Amato, Francesco Pisani, Emiliano Laudadio, Maurizio Cammalleri, Martina Lucchesi, Silvia Marracci, Luca Filippi, Roberta Galeazzi, Maria Svelto, Massimo Dal Monte, Paola Bagnoli

Summary: The hypoxia-inducible factor (HIF)-1 plays a major role in the homeostatic response to hypoxia by activating genes involved in neovessel proliferation. In the retina, hypoxia leads to overstimulation of beta-adrenoceptors (beta-ARs) and the formation of pathogenic blood vessels. This study demonstrates that HIF-1 regulates the expression of the beta 3-AR gene in the retina, and its involvement in the hypoxia response.

CELLS (2022)

Review Biochemistry & Molecular Biology

Neurosensory Alterations in Retinopathy of Prematurity: A Window to Neurological Impairments Associated to Preterm Birth

Martina Lucchesi, Silvia Marracci, Rosario Amato, Luca Filippi, Maurizio Cammalleri, Massimo Dal Monte

Summary: This article reviews the literature data on retinopathy of prematurity (ROP) and discusses whether ROP can be considered a neurodegenerative disease. It also describes the neurologic damage and outcomes associated with ROP.

BIOMEDICINES (2022)

Article Pediatrics

Treating infants with 0.2% propranolol eye micro-drops drastically reduced the progression of retinopathy of prematurity

Rosa Teresa Scaramuzzo, Paola Bagnoli, Massimo Dal Monte, Maurizio Cammalleri, Alessandro Pini, Sandy Ballini, Anna Bendinelli, Ielizza Desideri, Massimiliano Ciantelli, Luca Filippi

ACTA PAEDIATRICA (2023)

Article Biochemistry & Molecular Biology

Fetal Oxygenation from the 23rd to the 36th Week of Gestation Evaluated through the Umbilical Cord Blood Gas Analysis

Luca Filippi, Francesca Pascarella, Alessandro Pini, Maurizio Cammalleri, Paola Bagnoli, Riccardo Morganti, Francesca Innocenti, Nicola Castagnini, Alice Melosi, Rosa Teresa Scaramuzzo

Summary: The embryo and fetus grow in a hypoxic environment and intrauterine oxygen levels fluctuate throughout pregnancy. A retrospective study on healthy newborns with gestational age < 37 weeks showed a progressive decrease in oxygen levels starting from the 23rd week until the 33-34th week of gestation, followed by an increase in fetal oxygenation until birth. This biphasic trend indicates the role of placenta in regulating oxygen availability to promote stemness and differentiation at specific times and tissues.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available